ReNAgade Therapeutics

ReNAgade has been acquired by @Orna_Tx. With our combined capabilities, we aim to reshape the landscape of #RNA-targeted therapies and modalities to explore new possibilities in CAR therapy, gene editing and more. Read more here: ornatx.com/orna-therapeut… #Biotech #Biopharma

A landmark day for RNA therapeutic research: ReNAgade has been acquired by @Orna_Tx. With our combined industry-leading technologies we are poised to expand development of RNA engineering and address the unmet needs of a range of diseases. Read more here: ornatx.com/orna-therapeut…

We are thrilled to welcome Sivakesava Sakhamuri this week as our new Chief Technology Officer. With his exceptional leadership and expertise, our team eagerly anticipates working together to continue unlocking the potential of RNA medicines.

At #ASGCT2024, ReNAgade is presenting an oral and poster presentation highlighting preclinical data supporting our RNA technology platform. More information: bit.ly/4d6BBCG

This Saturday, ReNAgade CSO Pete Smith is presenting on recent discoveries in extra-hepatic delivery of #RNA cargoes and how ReNAgade’s portfolio of RNA delivery systems aim to overcome current limitations. More details: bit.ly/3PF798D

Tomorrow, our CEO Amit Munshi will participate in a fireside at the Evercore ISI Emerging Biotech Conference, where he will discuss ReNAgade’s multi-modal RNA platform and upcoming milestones. Webcast can be found here: bit.ly/3uMVDRs

Welcome Joe Bolen, joining us as ReNAgade’s Chief Scientific Innovation Officer. With 45 years of experience in oncology and immunology, his leadership will be invaluable as we continue to drive our lead programs towards development milestones. Read here: bit.ly/3UR6bJX

At #JPM2024 next week, ReNAgade CEO Amit Munshi will present on the exciting updates we are making across our broad portfolio of novel RNA medicines. More details: bit.ly/48IpqJs

Welcome Paul Perreault to ReNAgade’s Board of Directors! With over 40 years of leadership experience across the biotechnology industry, Mr. Perreault will be invaluable as we continue to build our portfolio of novel RNA medicines. Read more: bit.ly/3t3Sz2u

Dunk tanks, refreshing people, and all-team problem-solving are just a few of the reasons Reggie, Kimberly, and James are happy with the ReNAgade #experience. renagadetx.com #biotech #experience #dunktank

We’re honored to have been nominated by @NewEnglandVCas Emerging Life Science Company of the Year at the #NEVYs23. We’re excited for the recognition and look forward to celebrating with the rest of the nominees!

Gain insights from Trevor, our Gene-Editing Co-op, as he shares about his experience at ReNAgade this semester. #intern #careers #biotech

At #mRNA2023, ReNAgade will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-based delivery of mRNA to extra-hepatic tissue in a plenary session on 11/1 at 3:18PM CET (10:18AM ET). Full press release: bit.ly/3QByFVw @mrnaconference

Taylor in Delivery Chemistry shared his favorite part about the #culture at ReNAgade…we’ll give you a hint: 🎶 🎸 🎙️

At ReNAgade, we work hard to ensure you have the connections, opportunities, and training you need to succeed. We truly believe our potential comes from helping you realize yours. #careergrowth #culture

Want to work on the ground floor of cutting-edge medicines, receive competitive compensation, and enjoy impressive benefits? Check out our openings today: ow.ly/6biT50PQqI5 #biotech #careers

When it comes to competition, sometimes it’s a little more than friendly at ReNAgade. Check out our CSO Pete Smith getting dunked by Brian Shuster, our CBO, and his daughter during our Kimball Farms outing. #culture #bitotech

The culture at ReNAgade is something we are proud of and fully committed to curating as we grow. Don’t take it from us, hear what our team has to say. #culture #biotech

Congratulations to Karolina and Juan for receiving the Annual Hero Award! 🏆⭐️ The Hero Award is awarded to two members of ReNAgade who embody our core values and have had a positive impact on our culture and organization. Thank you so much Karolina and Juan! #biotechnews

We’re committed to your future and the future of RNA medicines. Hear from our team why ReNAgade might be right for you. #biotech #careers ow.ly/nUYe50PQnFy